Live Chat ×
Skip to main content

AML Non Transplant Treatments: What's in the Pipeline?

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Michael Savona, MD

    Dr. Michael R. Savona, M.D., F.A.C.P. serves as Associate Professor of Internal Medicine and Director of Early Therapeutics, Hematologic Malignancies at Vanderbilt University. Dr. Savona serves as a Member of Scientific Advisory Board at Karyopharm Therapeutics, Inc. He has also served as a Director of Hawaii Medical Service Association and as Director of Leukemia Research, at Sarah Cannon Research Institute where he spearheaded efforts to develop a Phase I program in Hematology. He has been the Principal Investigator on dozens of clinical studies and has been the lead investigator on studies of variety of novel compounds in hematologic malignancies. He has been involved medical research for 20 years and has published extensively in major academic journals including Nature Medicine, Blood, Cell Stem Cell, JAMA and Nature Cancer Reviews. He is board certified in medical oncology, hematology and internal medicine and is an elected fellow of the American College of Physicians. Dr. Savona obtained his bachelor’s degree in philosophy from Davidson College and medical degree at Wake Forest University School of Medicine in Winston-Salem, North Carolina.

May 22, 2018
Tue 1:00 PM EDT

Duration 1H 30M

This live web event has ended.